Newsletter Subject

Oxfam’s petition to Biden and Big Pharma

From

oaaf.org

Email Address

action@oaaf.org

Sent On

Mon, Mar 14, 2022 08:13 PM

Email Preheader Text

Add your name in support of vaccine equity | 113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7j

Add your name in support of vaccine equity | 113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jXV3q3npV1-WJV7CgMSgW21c1nK7-bmn-W52lxzR7cLKvvW9gwBLH3mDyWHW54-Fr16tkVHFW1mSVgm66ytftW4F7Jzf4hl-NNW91D6sF4dTdWVW50V0Lq6krnpCW4nFvCS23Z3r8W3pkLB24bB4QTN4vMJzN2YMn_W36vS0m6PSr3MW8jNnYS5RW7xhW3vY2MT80VZ0ZF6RFScgprN4W2ZlR2K5T0nWCW7QP99V36l37PW1qjVG-5c9dx3N58cMr2z5bZzW24sMCg17gWshW38YZS14m_zYcW7BRH6t2vRZv-3fNf1 [Oxfam](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jXV3q3npV1-WJV7CgH3mN6D4h1zsLSWnW49KF6G442M2DW7FFycm2d3GqGW68Nj071h3ltrW8J3hR46lhnSKW5TqmZJ895mjwVvdZsF1ykgCmN7_99RkRjPMsW88Gk2p8M3y-9VSBY4W4FsFGBN1sn2MHmsm3VW6KX5gV4jJKqGW5M-JvF4k7cC1W22hMyF1yz_Q5W48Zgq52NmJhHW2z8fKZ3-503KW434-kR6lTwZCW8z0Jqg7sBB68W9cZWzz8nL6GZW5fqrzX4ySlyrW737vZm93670gW8b02Xh53zsqM3ln11) Friend, Despite loosening pandemic restrictions here in the US, we can’t lose sight of the fact that people in many low and middle-income countries are living in a drastically different reality. The COVID-19 death toll has been three times higher in lower-income countries than in rich ones. While rich countries squander excess doses, Pfizer has delivered less than one percent of their total vaccine supplies to low-income countries while Moderna has delivered just 0.2 percent. Two years into this pandemic, you would think they would realize that no one is safe until everyone is safe. Join us in reminding them: [Friend, sign on and demand that leaders and Big Pharma equalize global production and distribution for the COVID-19 vaccine.](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jXh5nCT_V3Zsc37CgzGLW8R2nL43MGvC8W2ccwMB1HzdFcW9fdHJ16fDLKBW96JhBx2Kp3HqW56vtBm6Lx161W4zJCMT7MY1g9W20vjtY1XcM-DW56cBlj28PltHVXBCxx1NLDqtW7PDCm94R5cRgW5L7rTX489HsRW76CjxX3KbGVcW6Nk8Bz7NT-WLW3ZSZhw7nfXJFVyLKrt1G5VhYW4BKfn05J5TkLW86n3DX4HkXWQW4r_lNP4p-PJFVZ1K3W35q-_BN7zvXnt7pbgQW7xJvc25r3ksgW2QP9373NZqcLW5yfN3h6n8Z1YW6cQqDb90gB27W5hvlJy49krszW5ntQF-36S9_WN6ttf7SlLqywW7gZK308LBZplW2myw4C4x4mYJW86cT_b4dmFfFW8szcxr1H0lrGW8lhHgN1LRWkgW2nFqr35b8PW4W6yqKb23-5R343f4_1) [Speak Up for Vaccine Equity](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jW_7m8mVV5X_Kf7CgQHWV-s3Y15rp1Z-W15jp_y16VNhBW9j1Y7772qxGMV2GH8p7L9cd_W949KSM6CnfPpW4t-rcd65q6GKW7mQtB_9fkwJKW3-mRfL7WvtcLN3Xw_p165Q1_W3w5gbh3BkvM4W37Q5nV701FM6W5vBYg56y7kr2N7GNb_SjCH5BW58hnpN3F4ClTW7RT11r5-vFQQW6lyf1W6Gcf9FW40nFLD7Hmb9YW2DW4qj8G-txrW72fFwn86TddBW9jCZV87zHBGsW6mZ-v823Ht3PW3nhv543k8shsW4GtrxV3x76v_W6tmDHH3YCdk1N2RFNcpGcnsNW4fD-F-2Hd5RVW1xftgC8XszZhW6GN4P53C2gdsW5N9N-B6kJcQNVzcfKm8LP_X9W3LsyHM1F1t7LW25nwr61lm9LjV2PYfP3c6ZNDW5hx-Z94myVy5W3gw9Kt6VB5WPW3PnNKS2WKBhyW5tp2BH4WM3h2W668Qtd2bpmbHVtrpZ_3cZC90W5Cyv6S62mZ7HW6dNgY-6Jj--JW2cy9F74J6Hh1W5nB2Ml3Pw6VxW4fZG845tQWyvN7NfBCj_XH5JW7SRfSS3ctD9WW8g4twS7Srt9xW6rKDgv3w-N8G3m7C1) [Any Covid-19 vaccine is 0% effective for those who can't access it.](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jW_7m8mVV5X_Kf7CgLXlW16tQff5mxkQKW5Nr8T41DPWrRW3S3p0_1Cr-vVW2bNVdq7PlRFlW1mX9dR6QqCxNN4Mc45XDtr0rMQtLZ7gvJPpW6flYM71vt_wmW8Qt7Gf7HlN_pW3prCfY7Jp2qmW7ySPrn4yThCwW1-NW5n7PlsfcW8bPXlB3MM-WWW5mGq6-6YN7-xMVQx2D7HvF_W523G7Z7ZHcHQN2X6vQqfkmK9W6TtzM13vClhQW1JJvGX4nrBZMW9kSxk97dLXTYVv08Zx2Qjw7fVr_h6Z84hSLWW6-GG247qLxFwW12wHMs5glBLcN9k78vxxVk8gW85xT364sSbQnW22t9gm1wsRzkF47-TTSx5G2W2lHG9V7sHx3GV5MYGF2pcxV2W3XNBqc3Cm7mKW7h-_Gv24CY_TW8PXxkH3dmTQdW6kZXr14MWGfKW6kwC9Q18K7jDW3JCYFt8N-wl-W6hXtVt1d0_BdN2RDSFmry7XDW22g1jL4R2_CWW5N7HqS1xj_tsN4Y09QZGDCgQW3tQQ778xJYY8W67Mg9w7YzbhkW4yn4W13g41K0W3Y3_5p1RqPmTW4H42mc8WXYCXW7N2lB56pfCY-W1zmX0M2DYwx135j91) Corporate greed is causing thousands of avoidable deaths each day, and the refusal to share vaccine recipes and technological know-how with low and middle-income countries have allowed variants like Delta and Omicron to extend the pandemic in every one of our communities. The only way to move forward is to take concrete action that holds big pharma accountable. [Add your name to our petition calling for pharmaceutical companies to share the vaccine recipe, technology, and know-how in order to speed up manufacturing to get as many doses out into the world as possible.](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jXh5nCT_V3Zsc37CgRyNW4W0MXj7NsDjnW5FSyjd72dn8NW1Z1hpY6sLBs-W806kxH6QhmYrW3bZ6TX8BRSFXW3LbHdH7hssPBW16zk-P7Jp40jN6S5BmTMBmSbW50dLyD5_qWJ1N3db_KDPpb5jW93CznM545kmgW4wBF1h1C09sjW7vy8fJ6wl2NbN5_xGqMwTpfFW1SCr-98KjRtgW99HWNh3JxMTnW8xm3MG4njpk6W87KH_N3tGFwVW3KvnZt2BflcHW3nb0wH57wwJjVL3S7K7jddHJW7PRt2D1xqw5TW6tVnW839kYT4W54Xwwq1brBZLVM1Q033QjCQbVcH4St3n_4YNW5KJbDg25CcXQW5txL6t8_5byZW6XJZsq6G81FdW2cgXQB6n3Zf5W46Pk5K3ZhCQvW74sqV59d1rL-W5r7PvC85Mf0PN3fCJdHmpv6B3pfs1) [Sign the Petition](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jW_7m8mVV5X_Kf7CgB4gW3bKbjS7mpRPwW5D8-Vg5XMqrgW5k1yw943_hD9W4YVQKZ611DgKW1PBr4P6wYSrSW1cXP-q10T5BmN3QRMJp1JbYgW2wf2p894MfNnW6xB86h3-m0MCW3yhHSv2tZL3jW3yHRTg5PL6cLVX7cfX56tJRjW4z-dW_4XFpmkW8JcMGR4z3Zt6VtFRg_5J1JPdW3wlgxN2r9QhkW194tnh4GJFxRM53Gd4vBxxLW83yPg_8212QCN6S9hcSVNxWGW5B7gD17QtmYCW8R-jZx7-qLyTW170Jc75HM6JmW421r9C7D-VW1W2k9c116CC1s3W4vRcx55XjhYqW732-Zv8dJf5TW5F7F8C1tGJL2W4sY1sN6rw6yHN8vDt-8CxGTqW3-St1k6nYH7_W1bBndz3KzB6sW6MnmY73hpWtmW9db8854nGc6xMqxPdbLc0HxW1_zxGs4MQ29CW23hQVX3gJL-VW1ZwS4b5YkQHFW5yVqh02_v7ClN3SC8V8-B5g9W6rNl4p1kky4xN2lR5CYYZP9qV5XF3D2GxwYSN1PZ5Gd2ysnrW2hr3WS6vKkBkW2nSHRn2MtT_0W2kshQT78wJj3W5fdNHS7BcBK8386g1) Life may feel like it’s slowly getting back to normal, but that’s not the case in much of the world. We can’t afford to wait and see, we have to push those in power to take immediate action. [Sign your name and demand that President Biden and Big Pharma work with world leaders to ensure that everyone, everywhere has access to the vaccine.](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jXh5nCT_V3Zsc37CgzFYVM34gP2Z9wBtW811-w1509dx0W4y1SlX3tjdHpN7V85GWxWzBrW61jqjj5kcSp9W1zVSrk1Z7vfFW8RQskg7FBLngW19wq5M8vVMW8W85XwX492VxdTW26MmPR7-5nkWW314-nF1RyCSVW8VtWWJ64sKG5N2Mp4_fP72qnW29WjjT8TVxd6W3yL5hT7svXs9W3n6VR_3rLzj4M2sDrmC6tDrN5g_dTxMfTSNW1xKF_G168N2DW2RC0X-2Z5cxBW8Qwf9t3sdYGXW4ggzD34FyPDMW3K1nQ0264__nW3hfQ1P83Z9GsW1NnwDq3KxBb5W8k9XDN14vjlVW4nBf2M7DJ86zVDs_rJ2prtSJW2_PL537TpQT1W1QyCQN61mLLpW3jC3sy6YbNKsW3Xg3f453zY-GW7fr-L889NzYzW7HZgP35tZk3W35zK1) Thank you for mobilizing with us, Gina Cummings Vice President of Advocacy, Alliances, and Policy Oxfam America Action Fund This email was sent to {EMAIL}. If this isn't the best way to reach you, let us know your new contact information by emailing us [here](mailto:action@oaaf.org). Oxfam is only able to save lives and combat hunger, poverty, and injustice because of dedicated supporters like you, and we always love to hear your ideas. Feel free to send us any comments or feedback you have [here](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jZ33q3pBV1-WJV7CgDBkW4M9d3V74CdYyW7n9Q9T27WPs7W2jb2PX5sy640MkMM-XLwMFWW1W2HFw249Pb3W74nvfJ6t2smdW8W53k55Q4KzJW444D4K57WY5ZVGFmFy1VmfS7N8wpw9DBKb8mN6sqxqMjLYmdW3vNRcl7ShqwxV1NyLw7LTvv3W5RS1J-5Cpg00N5-4FGG2fMyvVLJYxy6rS1N4W3tcJN78v3k_BVd7Qvd4BS_57W2MXK0k3wVd9dW455FzN3qkJCSW7Fp0_b7Jxqb2W1Txj1p3XsWJ_N7J1sHxgNsDVW78sJ953Mz-yKW5l04wr6sC1LZW8gdvxT4SGDSjW333wp23_dcNqW7SYR9C76-szlW3VHPJ_8h3v-pW3MMJ1j8NXy0V3kZS1), or just reply to this message. Reaching you over email is the best way we have to let you know about the ways you can fight hunger and poverty around the world. If you no longer want to receive Oxfam email, you can do that [here]( but know that it will be harder for you to stay involved with Oxfam and continue the work that you've been such a critical part of. Thanks so much for your support. [Donate](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jY95nCVVV3Zsc37CgBKWW54pz_97VzwyTW285LSj4xMB_fW2Pzg6d4CJbqxW18KP5G4rHl7NN7xwNPC23zCrW4hM0LM90y8BdW53TzYC37VS2JW3PzL4_5qLCJBW80BK-l12LG4zW5HYW3743j8FdW7Kn_6K49YSzZW5XZTb85SgZ3GN1Zn2WbBdslJN46F9z7g2d5hW4pv_tk4HDhSZN6YXcTHDFrYtW27Mdmd3nqJpPW6TXHvP2YtpgBW407Y3l75-QJLVYH8Qb9dQTrwW79xm_w6_lt_QW68C3NK1-t3tmW7HM43D68bR_GW3KvLrc7Nk5cGW4htXjn5jGqh9W3Wgxr75DY6fBW20D3Hm6ZZ49yW16KvW63Ys5txW8Hbbbv6tSbjkVNDdTT3vx3G7N7J8NsZY5zF0VqMq7t7JmjJ_W44HwzL5hRCwkW4Pfr377MkR2jW8st_Tf6SkC2-W5DVn1D3BsYw-W4q98VW8H6FVbW5hTpDM4XGBvQW1v3YTY5sg5PhV9gMfy7V56m53mkS1) | [Contact us](113/cssrH04/VX5bJN1LsTQYW98w4G88-8zTYW805GfB4GFSkcN6D7jZ33q3pBV1-WJV7CgTf8W5jSl-Z2wRTl5VG7f9b3PVsHQW680m488P9M1ZW2jw9fb4qcF7mN6k-D5h1YWNqN2nyBVRq4WZpW5JPqX34mKhSXW2Q3NQs7GW4mfW2tV_Rp3pF-D8VQcrWC8Td99LN7zRlngwbqYBVS_13c4bT-ssW6T3BkR1m6DbgN3961c3KDxsVW25TMkk5tH51SW76S0682tny87N7p5Ggs-fNj6W3Kcd8z3hbnlnW4vyJFj9knF_DW3QKJZx91L5wTW7tqsPG4ht3RlW5nXRJH88yFFdW5870Dj5c04gYW7C429K2p-s2kN2vXTR_zfSkyW3TSRKS3W_nrJW1LDdbm1r9qQzW1Xr-tp2Cx2MQW4D7R7r5N0kbcW2FvXXh43FPll34HK1) Oxfam 226 Causeway Street, 5th Floor Boston, Massachusetts 02114 USA

oaaf.org

Gina Cummings, Oxfam America Action Fund

Marketing emails from oaaf.org

View More
Sent On

17/01/2023

Sent On

09/11/2022

Sent On

07/11/2022

Sent On

07/11/2022

Sent On

07/10/2022

Sent On

12/08/2022

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.